Jacobs Levy Equity Management, Inc Insulet Corp Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$260.36 - $307.27 $1.63 Million - $1.92 Million	-6,247 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$225.52 - $304.06 $37,887 - $51,082	168 Added 2.76%	6,247 $1.72 Million
Q1 2021 May 17, 2021	SELL	$235.95 - $293.05 $5.25 Million - $6.52 Million	-22,247 Reduced 78.54%	6,079 $1.59 Million
Q4 2020 Feb 16, 2021	BUY	$215.97 - $265.89 $4.13 Million - $5.09 Million	19,143 Added 208.46%	28,326 $7.24 Million
Q3 2020 Nov 16, 2020	BUY	$192.55 - $236.59 $181,574 - $223,104	943 Added 11.44%	9,183 $2.17 Million
Q2 2020 Aug 17, 2020	BUY	$159.17 - $224.73 $1.31 Million - $1.85 Million	8,240 New	8,240 $1.6 Million

753

63.3M

467K

639K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.5B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.